Jade Biosciences, Inc. · NASDAQ:JBIO
FMR LLC reported a 14.70% stake in Jade Biosciences, Inc. (Schedule 13G)
Event May 30, 2025 · Filed Jun 6, 2025
FMR LLC reported a 14.70% stake in Jade Biosciences, Inc., 4,735,951 shares, as a passive investor on May 30, 2025. Filed Jun 6, 2025 (Schedule 13G).
- Stake
- 14.70%
- Shares
- 4,735,951
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 14.70% | 4,735,951 |
| Abigail P. Johnson | 14.70% | 4,735,951 |
Source
Related
- Jade Biosciences, Inc.
- FMR LLC
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026